Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis.

Saved in:
Bibliographic Details
Title: Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis.
Authors: Clayton AH; aDepartment of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville bPfizer Inc., Collegeville, Pennsylvania cDepartment of Psychiatry and Institute for Women's Health, Virginia Commonwealth University, Richmond, Virginia, USA dPfizer Inc., Walton Oaks, UK ePfizer Canada Inc., Kirkland, Quebec, Canada., Hwang E, Kornstein SG, Tourian KA, Cheng RF, Abraham L, Mele L, Boucher M
Source: International clinical psychopharmacology [Int Clin Psychopharmacol] 2015 Nov; Vol. 30 (6), pp. 307-15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 8609061 Publication Model: Print Cited Medium: Internet ISSN: 1473-5857 (Electronic) Linking ISSN: 02681315 NLM ISO Abbreviation: Int Clin Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-5857
DOI:10.1097/YIC.0000000000000094